Maximus Inc (MMS) Stock
Key stats
- Market cap
- $3.42B
- Price / Earnings ratio
- 9.3x
- EPS (TTM)
- $6.82
- Volume
- Loading
- 52-week high
- $100.00
- 52-week low
- $51.04
- Dividend yield
- 1.97%
- Dividend amount (latest)
- $0.33
- Next earnings report
- 19 Nov 2026
Source: third-party data provider, as of November 13, 2026
Compare with MMS
Recent news

Maximus to Buy Agile Defense for $660M, Expanding AI and Cybersecurity Reach
Maximus to Buy Agile Defense for $660M, Expanding AI and Cybersecurity Reach
MMS

Can Maximus Weather the VA Contract Hit and Rebuild Earnings Momentum?
Can Maximus Weather the VA Contract Hit and Rebuild Earnings Momentum?
MMS

Is Maximus Stock Worth Buying as Low Valuation Meets Contract Risk?
Is Maximus Stock Worth Buying as Low Valuation Meets Contract Risk?
MMS

Maximus Q3 Earnings Call Highlights
Maximus Q3 Earnings Call Highlights
MMS
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 58.55
- MACD 12/26/9
- 2.19
- EMA 9 of MACD
- 2.23
- MACD histogram
- -0.04
- SMA 50
- $59.18
- Price above SMA 50
- EMA 50
- $60.99
- Price above EMA 50
- SMA 200
- $63.56
- Price above SMA 200
- EMA 200
- $66.48
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
No analyst data available
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of $2.18 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

Maximus to Buy Agile Defense for $660M, Expanding AI and Cybersecurity Reach
Maximus to Buy Agile Defense for $660M, Expanding AI and Cybersecurity Reach
MMS

Can Maximus Weather the VA Contract Hit and Rebuild Earnings Momentum?
Can Maximus Weather the VA Contract Hit and Rebuild Earnings Momentum?
MMS

Is Maximus Stock Worth Buying as Low Valuation Meets Contract Risk?
Is Maximus Stock Worth Buying as Low Valuation Meets Contract Risk?
MMS

Maximus Q3 Earnings Call Highlights
Maximus Q3 Earnings Call Highlights
MMS

Maximus Q3 Earnings Beat Estimates, Increase Year Over Year
Maximus Q3 Earnings Beat Estimates, Increase Year Over Year
MMS

Here's What Key Metrics Tell Us About Maximus (MMS) Q3 Earnings
Here's What Key Metrics Tell Us About Maximus (MMS) Q3 Earnings
MMS

Maximus (MMS) Q3 Earnings Beat Estimates
Maximus (MMS) Q3 Earnings Beat Estimates
MMS

Maximus (MMS) Could Be a Great Choice
Maximus (MMS) Could Be a Great Choice
MMS

Here's Why Maximus (MMS) is a Strong Growth Stock
Here's Why Maximus (MMS) is a Strong Growth Stock
MMS

Should Value Investors Buy Maximus (MMS) Stock?
Should Value Investors Buy Maximus (MMS) Stock?
MMS
News tone: automated (AI) classification of the article's content, not a price prediction.
About Maximus Inc
Maximus Inc designs, develops, and delivers programs enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments: U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment, which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Bruce L. Caswell | President, CEO & Director | 1967 |
| Mr. David W. Mutryn CPA | CFO & Treasurer | 1983 |
| Ms. Michelle F. Link | Chief Human Resources Officer | 1975 |
| Ms. Ilene R. Baylinson | General Manager of Health Services U.S. | 1958 |
| Ms. Theresa D. Golinvaux | Principal Accounting Officer, Senior VP & Corporate Controller | 1975 |
| Mr. Mike Raker | Chief Technology Officer | — |
| Mr. Derrick Pledger | Chief Digital & Information Officer (CDIO) | — |
| Ms. Elizabeth Moellering | General Counsel & Corporate Secretary | — |
| Mr. Jericho Seguin | Chief Corporate Development Officer | — |
| Mr. Jason Tone | Senior VP of Technology & Consulting Services of Healthcare | — |
Fundamentals
Valuation
Profitability
Trading
Dividend
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 58.55
- MACD 12/26/9
- 2.19
- EMA 9 of MACD
- 2.23
- MACD histogram
- -0.04
- SMA 50
- $59.18
- Price above SMA 50
- EMA 50
- $60.99
- Price above EMA 50
- SMA 200
- $63.56
- Price above SMA 200
- EMA 200
- $66.48
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
No analyst data available
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -9.4 | +6.9 | ||||||||||
| 2022 | -4.0 | +1.4 | -4.0 | -2.2 | -11.0 | -1.7 | +5.1 | -9.9 | -5.6 | +5.2 | +15.0 | +0.8 |
| 2023 | +1.2 | +8.4 | -4.0 | +4.8 | -3.9 | +3.5 | -1.3 | -3.4 | -7.6 | +0.6 | +11.2 | -1.5 |
| 2024 | -2.8 | +2.7 | +0.1 | -2.5 | +6.6 | -0.1 | +9.4 | +1.1 | +3.1 | -6.8 | -14.3 | +0.7 |
| 2025 | -0.7 | -14.0 | +6.0 | -2.5 | +9.3 | -1.4 | +3.0 | +20.6 | +2.2 | -8.5 | +3.2 | -0.8 |
| 2026 | +9.2 | -20.0 | -13.2 | +4.9 | -5.6 | -13.9 | +11.9 | -7.1 | -7.7 | +19.0 | -1.8 |



